Ratings changes for Nabriva Therapeutics, Trevena, Formula One Group, LiqTech International, Harvard Bioscience, Origin Agritech, Oncternal Therapeutics and more…Text “MarketBeat” to ย 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. ย Learn More.
While other cell phone carriers are always looking for ways to squeeze every last penny out of their customers, my company pays users for the 40 hours a week they are using smartphone apps, listening to music, and watching videos online with their phones.
And you can join us for just $0.26 per share. Plus, when you invest now, you can get up to 100% bonus shares!
Apple (NASDAQ:AAPL) will be releasing its Q2 2025 earnings after the market closes on Thursday, May 1. (View Earnings Report)
CFO Kevan Parekh sold 4,570 shares of the business’s stock in a transaction dated Wednesday, April 23rd. The stock was sold at an average price of $206.00, for a total transaction of $941,420.00. Following the completion of the transaction, the chief financial officer now directly owns 4,569 shares in the company, valued at approximately $941,214. The trade was a 50.01 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Alphabet saw some unusual options trading activity on Friday. Traders bought 631,804 call options on the stock. This is an increase of 73% compared to the typical daily volume of 365,513 call options.
ARMOUR Residential REIT (NYSE:ARR) was upgraded by analysts at Janney Montgomery Scott from a “neutral” rating to a “buy” rating.The current price is $16.39.
Boeing (NYSE:BA) was upgraded by analysts at Sanford C. Bernstein from a “market perform” rating to an “outperform” rating. They now have a $218.00 price target on the stock. This represents a 19.6% upside from the current price of $182.32.
Cognex (NASDAQ:CGNX) was upgraded by analysts at TD Cowen from a “hold” rating to a “buy” rating. They now have a $35.00 price target on the stock. This represents a 28.6% upside from the current price of $27.22.
Progressive (NYSE:PGR) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $312.00 price target on the stock. This represents a 16.4% upside from the current price of $267.96.
Peloton Interactive (NASDAQ:PTON) was upgraded by analysts at Truist Financial Co. from a “hold” rating to a “buy” rating. They now have a $11.00 price target on the stock. This represents a 66.8% upside from the current price of $6.60.
Tri Pointe Homes (NYSE:TPH) was upgraded by analysts at Wedbush from a “neutral” rating to an “outperform” rating. They now have a $43.00 price target on the stock, up previously from $38.00. This represents a 39.0% upside from the current price of $30.94.
Valero Energy (NYSE:VLO) was upgraded by analysts at The Goldman Sachs Group, Inc. from a “sell” rating to a “neutral” rating. They now have a $127.00 price target on the stock. This represents a 10.5% upside from the current price of $114.97.
Zions Bancorporation, National Association (NASDAQ:ZION) was upgraded by analysts at Argus from a “hold” rating to a “buy” rating. They now have a $55.00 price target on the stock. This represents a 21.8% upside from the current price of $45.14.
Zscaler (NASDAQ:ZS) was upgraded by analysts at BNP Paribas from a “neutral” rating to an “outperform” rating. They now have a $260.00 price target on the stock. This represents a 17.9% upside from the current price of $220.62.
The AI Stocks Under $15 You Donโt Want to Miss in 2025 (ad)
AI Is Changing EverythingโThese 2 Stocks Could Lead the Charge
From healthcare to finance, AI is driving a new wave of innovation. But while the biggest names grab headlines, the smartest opportunities may be elsewhere. This report highlights two undervalued AI stocks trading under $15โcompanies with real potential as the AI race accelerates in 2025.
Atmos Energy (NYSE:ATO) was downgraded by analysts at Mizuho from an “outperform” rating to a “neutral” rating. They now have a $164.00 price target on the stock, down previously from $165.00. This represents a 4.8% upside from the current price of $156.54.
Avantor (NYSE:AVTR) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. They now have a $14.00 price target on the stock. This represents a 12.3% upside from the current price of $12.47.
Avantor (NYSE:AVTR) was downgraded by analysts at TD Cowen from a “buy” rating to a “hold” rating. They now have a $15.50 price target on the stock. This represents a 24.3% upside from the current price of $12.47.
Chipotle Mexican Grill (NYSE:CMG) was downgraded by analysts at Argus from a “buy” rating to a “hold” rating.The current price is $52.21.
CONMED (NYSE:CNMD) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. They now have a $55.00 price target on the stock. This represents a 7.2% upside from the current price of $51.30.
Custom Truck One Source (NYSE:CTOS) was downgraded by analysts at Robert W. Baird from an “outperform” rating to a “neutral” rating. They now have a $5.00 price target on the stock. This represents a 17.9% upside from the current price of $4.24.
Saia (NASDAQ:SAIA) was downgraded by analysts at Bank of America Co. from a “buy” rating to a “neutral” rating. They now have a $251.00 price target on the stock. This represents a 3.4% upside from the current price of $242.71.
Top analysts are reporting that the average person will need at least $2 million to retire comfortably these daysโฆ
But when it takes an average of 41 years to turn a $100K of retirement savings into $1 millionโฆ
The odds are not in our favorโฆ
We canโt promise results or guarantee against losses, but thereโs no need to go another day without finding out how to target extra income with Jackโs help.
Akebia Therapeutics (NASDAQ:AKBA) is now covered by analysts at Leerink Partners. They set an “outperform” rating and a $7.00 price target on the stock. This represents a 194.7% upside from the current price of $2.38.
Brunswick (NYSE:BC) is now covered by analysts at Benchmark Co.. They set a “buy” rating and a $70.00 price target on the stock. This represents a 47.0% upside from the current price of $47.62.
Corporaciรณn Amรฉrica Airports (NYSE:CAAP) is now covered by analysts at Itau BBA Securities. They set an “outperform” rating and a $20.40 price target on the stock. This represents a 3.3% upside from the current price of $19.75.
Celldex Therapeutics (NASDAQ:CLDX) is now covered by analysts at Canaccord Genuity Group Inc.. They set a “buy” rating and a $64.00 price target on the stock. This represents a 215.8% upside from the current price of $20.27.
Co-Diagnostics (NASDAQ:CODX) is now covered by analysts at D. Boral Capital. They set a “buy” rating and a $10.00 price target on the stock. This represents a 2552.5% upside from the current price of $0.38.
Columbia Sportswear (NASDAQ:COLM) is now covered by analysts at Barclays PLC. They set an “equal weight” rating and a $64.00 price target on the stock. This represents a 2.1% downside from the current price of $65.40.
Corpay (NYSE:CPAY) is now covered by analysts at Oppenheimer Holdings Inc.. They set a “market perform” rating on the stock.The current price is $325.78.
Formula One Group (NASDAQ:FWONA) is now covered by analysts at Susquehanna. They set a “positive” rating and a $115.00 price target on the stock. This represents a 44.1% upside from the current price of $79.81.
Formula One Group (NASDAQ:FWONK) is now covered by analysts at Susquehanna. They set a “positive” rating and a $115.00 price target on the stock. This represents a 30.6% upside from the current price of $88.08.
InvenTrust Properties (NYSE:IVT) is now covered by analysts at BTIG Research. They set a “buy” rating and a $31.00 price target on the stock. This represents a 12.1% upside from the current price of $27.66.
LightPath Technologies (NASDAQ:LPTH) is now covered by analysts at Craig Hallum. They set a “buy” rating and a $5.50 price target on the stock. This represents a 126.8% upside from the current price of $2.43.
Live Nation Entertainment (NYSE:LYV) is now covered by analysts at Susquehanna. They set a “positive” rating and a $155.00 price target on the stock. This represents a 15.8% upside from the current price of $133.84.
MSG Entertainment (NYSE:MSGE) is now covered by analysts at Susquehanna. They set a “positive” rating and a $39.00 price target on the stock. This represents a 18.8% upside from the current price of $32.82.
Madison Square Garden Sports (NYSE:MSGS) is now covered by analysts at Susquehanna. They set a “positive” rating and a $254.00 price target on the stock. This represents a 30.1% upside from the current price of $195.25.
Symmetry Medical (NYSE:SMA) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $40.00 price target on the stock. This represents a 19.6% upside from the current price of $33.45.
Symmetry Medical (NYSE:SMA) is now covered by analysts at Truist Financial Co.. They set a “buy” rating and a $38.00 price target on the stock. This represents a 13.6% upside from the current price of $33.45.
Symmetry Medical (NYSE:SMA) is now covered by analysts at BMO Capital Markets. They set an “outperform” rating and a $40.00 price target on the stock. This represents a 19.6% upside from the current price of $33.45.
Symmetry Medical (NYSE:SMA) is now covered by analysts at Raymond James. They set an “outperform” rating and a $40.00 price target on the stock. This represents a 19.6% upside from the current price of $33.45.
Symmetry Medical (NYSE:SMA) is now covered by analysts at Wells Fargo & Company. They set an “overweight” rating and a $38.00 price target on the stock. This represents a 13.6% upside from the current price of $33.45.
Symmetry Medical (NYSE:SMA) is now covered by analysts at Scotiabank. They set a “sector outperform” rating and a $36.00 price target on the stock. This represents a 7.6% upside from the current price of $33.45.
Symmetry Medical (NYSE:SMA) is now covered by analysts at JPMorgan Chase & Co.. They set an “overweight” rating and a $36.00 price target on the stock. This represents a 7.6% upside from the current price of $33.45.
Symmetry Medical (NYSE:SMA) is now covered by analysts at Robert W. Baird. They set an “outperform” rating and a $38.00 price target on the stock. This represents a 13.6% upside from the current price of $33.45.
Symmetry Medical (NYSE:SMA) is now covered by analysts at KeyCorp. They set an “overweight” rating and a $38.00 price target on the stock. This represents a 13.6% upside from the current price of $33.45.
Sphere Entertainment (NYSE:SPHR) is now covered by analysts at Susquehanna. They set a “positive” rating and a $37.00 price target on the stock. This represents a 26.5% upside from the current price of $29.25.
TKO Group (NYSE:TKO) is now covered by analysts at Susquehanna. They set a “positive” rating and a $180.00 price target on the stock. This represents a 12.7% upside from the current price of $159.72.
Verona Pharma (NASDAQ:VRNA) is now covered by analysts at TD Cowen. They set a “buy” rating and a $100.00 price target on the stock. This represents a 46.3% upside from the current price of $68.37.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.